Talaris Therapeutics Inc (TALS)

(10% Negative) TALARIS THERAPEUTICS, INC. (TALS) Announces Delay in results Trials for our pipeline programs Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment